Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease

Ann N Y Acad Sci. 2017 Aug;1401(1):37-48. doi: 10.1111/nyas.13414.

Abstract

Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders that includes Crohn's disease (CD) and ulcerative colitis (UC). Homeostasis of various regulatory factors involved with intestinal immunity is disrupted in IBD, including the intestinal epithelial barrier, macrophages, and cellular mediators such as cytokines and chemokines. No successful treatment is currently available for the management of IBD. Natural products and herbal medicines have exhibited efficacy for UC and CD in experimental models and clinical trials with the following activities: (1) maintenance of integrity of the intestinal epithelial barrier, (2) regulation of macrophage activation, (3) modulation of innate and adaptive immune response, and (4) inhibition of TNF-α activity. Here, we discuss the major factors involved in the pathogenesis of IBD and the current development of natural products and herbs for the treatment of IBD.

Keywords: Crohn's disease; herbal medicine; inflammatory bowel disease; natural products; ulcerative colitis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products / chemistry
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Herbal Medicine / methods*
  • Herbal Medicine / trends
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / metabolism
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Phytotherapy / methods
  • Plant Preparations / chemistry
  • Plant Preparations / pharmacology
  • Plant Preparations / therapeutic use*
  • Treatment Outcome

Substances

  • Biological Products
  • Plant Preparations